Intervention Study Investigating the Effect of a Phospholipid Drink on Cognitive Performance in 6-8 Year Old School Children

NCT ID: NCT03705572

Last Updated: 2018-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

165 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-31

Study Completion Date

2015-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Six week RCT intervention on the effects of phospholipid containing milk drink vs. placebo milk drink on cognitive performance in 6-8 year old school children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomised, double blind, placebo controlled study with parallel groups investigating a 6 week intervention in 6-8 year old school children of phospholipid containing milk drink vs. placebo milk drink. Participants were familiarised with the test battery and IQ (Wechsler abbreviated scale of intelligence) and colour blindness (Ishihara test) measurements were taken prior to the intervention. Milk drink taste testing and milk preference selection was also carried out prior to the intervention. The test battery was administered at baseline (week 0), midpoint (week 3) and endpoint (week 6), and the milk intervention was given Monday - Friday at school shortly before their mid-morning break over a 6 week period. This study design, including both the test days and morning milk supplementation, was intended to emulate the children's normal routine as far as possible. The milk drink was a supplement to the children's usual diet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dietary Supplement: Phospholipid drink.

Participant in an intervention parallel group consumed a drink with added phospholipids (Lacprodan PL20).

Group Type ACTIVE_COMPARATOR

Lacprodan PL20

Intervention Type DIETARY_SUPPLEMENT

Milk protein concentrate that is high in phospholipid content (min 16%).

Dietary Supplement: Placebo milk drink.

Participant in an intervention parallel group consumed a drink without added phospholipids.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Placebo milk drink.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lacprodan PL20

Milk protein concentrate that is high in phospholipid content (min 16%).

Intervention Type DIETARY_SUPPLEMENT

Placebo

Placebo milk drink.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, aged 6-8 years.
* Willingness to consume milk drinks during the study determined by a score of \>5 on a taste testing Likert scale for at least one flavour of the milk drinks.
* Ability to follow verbal and simple written instructions in English.
* Normal vision, with appropriate corrective lenses if required.
* Ability to understand cognitive testing instructions and responding requirements.

Exclusion Criteria

* Poor general health.
* Colour blindness.
* Behavioural difficulties or attention disorders (e.g. Attention Deficit Hyperactivity Disorder).
* Learning disabilities that interfere with the ability to understand written or verbal communications.
* Inability to understand the objective of the cognitive tests, or carry out the tests.
* Any food allergies or intolerances (e.g. lactose intolerance).
* Acute illness, or feelings of unwell, within the week prior to testing.
* Current administration of any psychotropic medication or supplementation in the month prior to testing, or during testing.
* Hearing impairment that precludes the ability to follow verbal instructions.
* Children already receiving milk at school unless parents are willing to substitute current milk with the study milk.
Minimum Eligible Age

6 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arla Foods

INDUSTRY

Sponsor Role collaborator

University of Leeds

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof Louise Dye

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Louise Dye, PhD

Role: PRINCIPAL_INVESTIGATOR

Professor of Nutrition & Behaviour; Lead for Strategic Development.

Clare Lawton, PhD

Role: PRINCIPAL_INVESTIGATOR

Associate Professor of Nutrition & Behaviour.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Arla02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.